Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Critical Care|July 7, 2025
Ventilator-associated pneumonia: how long is long enough?Despoina Koulenti, Maria-Panagiota Almyroudi, Antonios KatsounasJournal of Intensive Medicine|February 14, 2023
COVID-19-Associated Pulmonary Aspergillosis (CAPA)George Dimopoulos, Maria-Panagiota Almyroudi, Pavlos Myrianthefs, et al.Ageing Research Reviews|December 24, 2022
The impact of age on intensive careKarolina Akinosoglou, Georgios Schinas, Maria Panagiota Almyroudi, et al.Diagnostics (Basel, Switzerland)|December 23, 2022
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive ReviewMaria Panagiota Almyroudi, Karolina Akinosoglou, Jordi Rello, et al.Viruses|May 27, 2023
Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral TreatmentGeorgios Schinas, Vasiliki Moustaka, Eleni Polyzou, et al.Journal of Fungi (Basel, Switzerland)|December 24, 2021
A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)Simon Feys, Maria Panagiota Almyroudi, Reinout Braspenning, et al.Antibiotics (Basel, Switzerland)|July 27, 2024
Novel Antibiotics for Gram-Negative Nosocomial PneumoniaMaria Panagiota Almyroudi, Aina Chang, Ioannis Andrianopoulos, et al.Antibiotics (Basel, Switzerland)|January 28, 2026
Duration Matters: Tailoring Antibiotic Therapy for Ventilator-Associated PneumoniaTim Rahmel, Isabella Traut, Lars Bergmann, et al.Antibiotics (Basel, Switzerland)|April 28, 2023
Novel Antimicrobial Agents for Gram-Negative PathogensMarios Karvouniaris, Maria Panagiota Almyroudi, Mohd Hafiz Abdul-Aziz, et al.Future Microbiology|May 3, 2024
Severe mold fungal infections in critically ill patients with COVID-19Despoina Koulenti, Elisabeth Paramythiotou, Maria Panagiota Almyroudi, et al.Pageof 2